DUBLIN, May 20, 2022--(BUSINESS WIRE)--The "Hydrogels - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Hydrogels Market to Reach $16.7 Billion by 2027
The global market for Hydrogels estimated at US$12.1 Billion in the year 2020, is projected to reach a revised size of US$16.7 Billion by 2027, growing at a CAGR of 4.7% over the analysis period 2020-2027.
Natural, one of the segments analyzed in the report, is projected to record a 4% CAGR and reach US$5.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Synthetic segment is readjusted to a revised 5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 6.7% CAGR
The Hydrogels market in the U.S. is estimated at US$3 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 6.7% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.
Hybrid Segment to Record 5.7% CAGR
In the global Hybrid segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$946.6 Million in the year 2020 will reach a projected size of US$1.4 Billion by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.4 Billion by the year 2027, while Latin America will expand at a 6.8% CAGR through the analysis period.
Impact of Covid-19 and a Looming Global Recession
Expanding Applications and Product Innovations Spur Growth in the Global Hydrogel Market
Emerging Economies to Post Strong Growth
Industry Witnesses Rise in Demand for Synthetic Hydrogels
Synthetic Hydrogels by Polymer Type: A Snapshot
Competitive Market Presence - Strong/Active/Niche/Trivial for 59 Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS (Total 59 Featured)
Innovations Expand Addressable Market for Hydrogels
Rise in Incidence of Chronic Diseases and High Treatment Costs Drive Demand for Hydrogel Dressings for Wound Healing
Global Wound Care Market: Percentage Breakdown of Spending by Wound Type
Personal Care Product: An Evolving Niche Market
Consumer Adoption of Hydrogel Contact Lenses Augurs Well for Market Growth
Hydrogels Evolve as Emerging Alternative for Food Packaging
Agriculture Sector Depicts Strong Growth Potential
Global Water Utilization: Percentage Share Breakdown for Agricultural Practices, Industrial Processes, and Domestic Usage
Rising Concerns over Polluting Water Resources: An Opportunity for Hydrogels Market
Need for Wastewater Treatment Presents Opportunity for Hydrogels: Percentage of Wastewater Treated in Europe, Asia, Latin America, and Africa
Growing Emphasis on Sustainability and Positive Impact on Hydrogels
Growth in Biomedical Applications of Hydrogels
Growing Need for Targeted Controlled Drug Delivery (TCDD) Drives Importance of Hydrogels
Hydrogel Nanoparticles: The New Hydrogels for Drug Delivery
Evaporative Cooling Hydrogel Packaging: Increasing Storage Stability of Pharmaceuticals
Growing Focus on Baby Hygiene Products Spells Steady Growth Opportunities for Hydrogels
Annual Usage of Baby Disposable Diapers Per Infant by Region (Age up to 2.5 years)
Global New Births (in Millions) per Annum by Geographic Region
World Fertility Rate in % by Region (2013 & 2050F)
Increased Demand for Feminine Hygiene Products
Aging Population and the Associated Complications Drive the Demand for Hydrogel
Rise in Demand for Novel Hydrogel Dressings for Wound Healing Propels Innovations
Select Natural Hydrogels: Advantages and Disadvantages
Select Synthetic Hydrogels: Advantages and Disadvantages
For more information about this report visit https://www.researchandmarkets.com/r/5s7l7p
View source version on businesswire.com: https://www.businesswire.com/news/home/20220520005346/en/
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Shareholders in Amazon (NASDAQ: AMZN) beat a rising market on Friday morning, with shares gaining 3% by 10:45 a.m. ET compared to a 1.4% boost in the S&P 500. The rally was powered by a brightening outlook around economic growth and consumer spending. A major factor driving Amazon's stock higher on Friday was the boost in the wider tech world.
The Dow Jones rallied amid encouraging inflation data. Tesla stock jumped even as CEO Elon Musk issued a warning. Apple stock surged.
(Bloomberg) -- Fertilizer prices that had hit records are now plunging as buyers reel from sticker shock, but that doesn’t mean the market squeeze is over. Most Read from BloombergFord Beats Tesla to the Punch With First Electric F-150 DeliveryStocks Notch Their Best Week Since November 2020: Markets WrapUkraine Latest: US Slams Putin’s Food-for-Sanctions Relief PlanZilingo’s Fired CEO Responds to Questions of Mystery PaymentsThe June spot price in Tampa, Florida for the nitrogen fertilizer ammo
Stock splits have been all the rage in recent years, fueled by surging stock prices of some of the world's most recognizable companies. Worse still, the tech-heavy Nasdaq has tumbled into bear market territory, down roughly 27% from its high reached late last year. Read on to find out why they picked Amazon (NASDAQ: AMZN), Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG), and Shopify (NYSE: SHOP) from among the recent stock-split candidates.
Stop investing in mediocre businesses. Buy the best, instead.
Shares of Moderna (NASDAQ: MRNA) were jumping 7.5% higher as of 11:30 a.m. ET on Friday. Instead, Moderna appears to be benefiting from the overall stock market bounce. Good news for the overall stock market tends to be good news for Moderna.
As of 12:24 p.m. ET, Aurora shares were still down 38.8%. At the same time, Tilray (NASDAQ: TLRY) shares were down 3.6%, and Hexo (NASDAQ: HEXO) stock was down 5.3%. The plunge in Aurora shares comes as existing shareholders react to a new round of financing that the company said will bring $150 million to the company.
In this article, we discuss the 10 stocks that Jim Cramer and hedge funds agree on. If you want to read about some more stocks that Jim Cramer and hedge funds agree on, go directly to Jim Cramer and Hedge Funds Agree on These 5 Stocks. In the past few weeks, Jim Cramer, the journalist […]
Julian Bridgen, co-founder and president of Macro Intelligence 2 Partners, joins Yahoo Finance Live to discuss this week's market action and whether or not it will carry over into next week, the Fed, and inflation.
Tesla CEO Elon Musk announced his plans to open an all-night Tesla restaurant in Hollywood that will feature a drive-in movie theater, two 45 ft. LED movie screens, and superchargers.
Ulta shares are up after its big Q1 earnings beat, Aurora Cannabis increased its finance deal to $150 million, and Blackberry stock is surging after news of its partnership with Google.
Despite all the attention that renewable energy companies get, having operations in the renewable energy space alone does not make a stock a buy. In fact, several renewable energy companies are struggling just to stay profitable. Let's discuss two renewable energy stocks that look attractive right now, and one that's best avoided.
In this article, we will look at 10 undervalued stocks to buy according to billionaire Leon Cooperman. If you want to skip reading about Leon Cooperman’s early life, investment philosophy, and his hedge fund’s performance, you can go directly to 5 Undervalued Stocks to Buy According to Billionaire Leon Cooperman. Leon Cooperman is an American […]
Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success. And there are no stocks that better embody both sides – the risk factors and the reward potentials – than penny stocks. These equities, priced below $5 per share, typically offer high upside potentials. Even a small gain in share price – just a few cents – quickly translates into a high yield return. Of course, the risk is real, too; not every penny stock is going to show th
Qualcomm CEO Cristiano Amon weighs in on the outlook for the semiconductor industry and his company's future.
Some investors turned to nonfungible tokens in search of a haven among digital assets in the first quarter. However, the bets soon turned sour.
The cannabis company's per-share loss was almost five times as big as analysts had expected. The stock plunged in response.
Let's begin today's review with Livent, which has the most obvious good news powering its rally. Early this morning, Livent announced that it will collaborate with electric air-taxi start-up Lilium N.V. (NASDAQ: LILM) to jointly develop new lithium metal technology for use in high-performance battery cells.
Shares of Dutch Bros (NYSE: BROS) are rocketing higher this week, surging 34.1% compared to where they closed last Friday, according to data from S&P Global Market Intelligence, riding a meme stock wave of buying. After it was reported that short interest in the coffee shop shot up almost 30% in the latest period, stock traders who populate various internet stock chat rooms piled into the stock. Meme stocks, of course, are stocks that trade more on social media chatter than on business fundamentals, though in Dutch Bros' case the underlying business is pretty good, too.
Tesla won't set up a manufacturing plant in India until it is first allowed to sell and service cars in the South Asian nation, the carmaker's chief executive Elon Musk said Friday, more than a year after an Indian state said that the electric carmaker was planning to open a plant in the southern part of the country. Responding to an individual on Twitter, who had asked for an update on Tesla's manufacturing plant in India, Musk responded, "Tesla will not put a manufacturing plant in any location where we are not allowed first to sell & service cars."